ArticleJournal of research in pharmacy practice
Impact of Community Pharmacy Vaccination Services on Respiratory Vaccine Coverage of Patients Taking Immunosuppressive Medications in Quebec, Canada.
Article in Journal of research in pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Immunocompromised patients are at increased risk of bacterial and viral respiratory infections and related complications. Available vaccines against these infections are the most effective tools in preventing complications. Community pharmacist vaccination service is evolving in many countries, and they could present an opportunity to improve vaccination coverage in this population. This study aims to describe how community pharmacists are involved in vaccinating high-risk (immunocompromised) populations. Methods: This retrospective study included vaccination information of patients who received chronic immunosuppressive therapy among those who were taking selected chronic medications from community pharmacies in Montreal, Canada, from January 2020 to September 2023. Immunosuppressive therapy was categorized as either corticosteroids or immunosuppressive drugs or the combination of corticosteroids with one or two immunosuppressive drugs. Data were available from all private pharmacies through the Quebec Association of Pharmacists Owners database. Descriptive statistics are used for data analysis. Findings: Of the total number of 4,114,528 patients who were taking selected chronic medications from community pharmacies, 611,789 (14.8%) were taking immunosuppressives. Prednisone/prednisolone was the most commonly administered drug in this population (345,744 [8.4%]). Most of these patients are aged over 50 years (484,827 [79.2%]). A total of 409,171 (66.8%) co-administered at least one other drug. The vaccination rate was highest for influenza (142,877 [23.3%]) and lowest (23,532 [3.8%]) with the pneumococcus vaccine. Patients younger than 25 had the lowest vaccination rate with three respiratory vaccines. Vaccination rate decreased after the pandemic with all three vaccines in our study population. Conclusion: Vaccination rates of patients taking chronic immunosuppressive drugs in community pharmacies are low. These rates are worse than rates for other high-risk groups from the same database. This represents a missed opportunity for pharmacists to encourage this high-risk population to vaccinate proactively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.